Skip to main content
Top
Published in: Calcified Tissue International 4/2014

01-04-2014 | Original Research

Fructus ligustri lucidi Ethanol Extract Improves Bone Mineral Density and Properties Through Modulating Calcium Absorption-Related Gene Expression in Kidney and Duodenum of Growing Rats

Authors: Xin Feng, Ying Lyu, Zhenghao Wu, Yuehui Fang, Hao Xu, Pengling Zhao, Yajun Xu, Haotian Feng

Published in: Calcified Tissue International | Issue 4/2014

Login to get access

Abstract

Optimizing peak bone mass in early life is one of key preventive strategies against osteoporosis. Fructus ligustri lucidi (FLL), the fruit of Ligustrum lucidum Ait., is a commonly prescribed herb in many kidney-tonifying traditional Chinese medicinal formulas to alleviate osteoporosis. Previously, FLL extracts have been shown to have osteoprotective effect in aged or ovariectomized rats. In the present study, we investigated the effects of FLL ethanol extract on bone mineral density (BMD) and mechanical properties in growing male rats and explored the underlying mechanisms. Male weaning Sprague–Dawley rats were randomized into four groups and orally administrated for 4 months an AIN-93G formula-based diet supplementing with different doses of FLL ethanol extract (0.40, 0.65, and 0.90 %) or vehicle control, respectively. Then calcium balance, serum level of Ca, P, 25(OH)2D3, 1,25(OH)2D3, osteocalcin (OCN), C-terminal telopeptide of type I collagen (CTX-I), and parathyroid hormone, bone microarchitecture, and calcium absorption-related genes expression in duodenum and kidney were analyzed. The results demonstrated that FLL ethanol extract increased BMD of growing rats and improved their bone microarchitecture and mechanical properties. FLL ethanol extract altered bone turnover, as evidenced by increasing a bone formation maker, OCN, and decreasing a bone resorption maker, CTX-I. Intriguingly, both Ca absorption and Ca retention rate were elevated by FLL ethanol extract treatment, possibly through the mechanisms of up-regulating the transcriptions of calcitropic genes in kidney (1α-hydroxylase) and duodenum (vitamin D receptor, calcium transporter calbindin-D9k, and transient receptor potential vanilloid 6). In conclusion, FLL ethanol extract increased bone mass gain and improved bone properties via modulating bone turnover and up-regulating calcium absorption-related gene expression in kidney and duodenum, which could then activate 1,25(OH)2D3-dependent calcium transport in male growing rats.
Literature
1.
go back to reference Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P et al (1990) Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263:665–668PubMedCrossRef Cummings SR, Black DM, Nevitt MC, Browner WS, Cauley JA, Genant HK, Mascioli SR, Scott JC, Seeley DG, Steiger P et al (1990) Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA 263:665–668PubMedCrossRef
2.
go back to reference Melton LR, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) How many women have osteoporosis? [Perspective]. J Bone Miner Res 7:1005–1010PubMedCrossRef Melton LR, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) How many women have osteoporosis? [Perspective]. J Bone Miner Res 7:1005–1010PubMedCrossRef
3.
go back to reference Wang L, Banu J, McMahan CA, Kalu DN (2001) Male rodent model of age-related bone loss in men. Bone 29:141–148PubMedCrossRef Wang L, Banu J, McMahan CA, Kalu DN (2001) Male rodent model of age-related bone loss in men. Bone 29:141–148PubMedCrossRef
4.
go back to reference Li ML (1994) Progress in the study on Fructus ligustri lucidi. Zhongguo Zhong Yao Za Zhi 19:504–506PubMed Li ML (1994) Progress in the study on Fructus ligustri lucidi. Zhongguo Zhong Yao Za Zhi 19:504–506PubMed
5.
go back to reference Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS (2006) Effects of Fructus ligustri lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29:291–296PubMedCrossRef Zhang Y, Lai WP, Leung PC, Wu CF, Yao XS, Wong MS (2006) Effects of Fructus ligustri lucidi extract on bone turnover and calcium balance in ovariectomized rats. Biol Pharm Bull 29:291–296PubMedCrossRef
6.
go back to reference Zhang Y, Dong XL, Leung PC, Che CT, Wong MS (2008) Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558–565PubMedCrossRef Zhang Y, Dong XL, Leung PC, Che CT, Wong MS (2008) Fructus ligustri lucidi extract improves calcium balance and modulates the calciotropic hormone level and vitamin D-dependent gene expression in aged ovariectomized rats. Menopause 15:558–565PubMedCrossRef
7.
go back to reference Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Br J Nutr 99:494–502PubMed Zhang Y, Leung PC, Che CT, Chow HK, Wu CF, Wong MS (2008) Improvement of bone properties and enhancement of mineralization by ethanol extract of Fructus ligustri lucidi. Br J Nutr 99:494–502PubMed
8.
go back to reference Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11PubMedCrossRef Lane NE (2006) Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol 194:S3–S11PubMedCrossRef
9.
go back to reference Pitkin RM (1985) Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 151:99–109PubMedCrossRef Pitkin RM (1985) Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 151:99–109PubMedCrossRef
10.
go back to reference Emkey RD, Emkey GR (2012) Calcium metabolism and correcting calcium deficiencies. Endocrinol Metab Clin N Am 41:527–556CrossRef Emkey RD, Emkey GR (2012) Calcium metabolism and correcting calcium deficiencies. Endocrinol Metab Clin N Am 41:527–556CrossRef
11.
go back to reference Gennari C (2001) Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr 4:547–559PubMedCrossRef Gennari C (2001) Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr 4:547–559PubMedCrossRef
12.
13.
go back to reference Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885–3894PubMedCrossRef Song Y, Peng X, Porta A, Takanaga H, Peng JB, Hediger MA, Fleet JC, Christakos S (2003) Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology 144:3885–3894PubMedCrossRef
14.
go back to reference Bouillon R, Van Cromphaut S, Carmeliet G (2003) Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem 88:332–339PubMedCrossRef Bouillon R, Van Cromphaut S, Carmeliet G (2003) Intestinal calcium absorption: molecular vitamin D mediated mechanisms. J Cell Biochem 88:332–339PubMedCrossRef
15.
go back to reference Christakos S (2012) Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys 523:73–76PubMedCentralPubMedCrossRef Christakos S (2012) Recent advances in our understanding of 1,25-dihydroxyvitamin D(3) regulation of intestinal calcium absorption. Arch Biochem Biophys 523:73–76PubMedCentralPubMedCrossRef
16.
go back to reference Clark J, Gebhart G, Gonder J, Keeling M, Kohn D (1997) The 1996 guide for the care and use of laboratory animals. ILAR J 38:41–48PubMedCrossRef Clark J, Gebhart G, Gonder J, Keeling M, Kohn D (1997) The 1996 guide for the care and use of laboratory animals. ILAR J 38:41–48PubMedCrossRef
17.
go back to reference Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313:856–862PubMedCrossRef Radonic A, Thulke S, Mackay IM, Landt O, Siegert W, Nitsche A (2004) Guideline to reference gene selection for quantitative real-time PCR. Biochem Biophys Res Commun 313:856–862PubMedCrossRef
18.
go back to reference Wada S, Kamiya S (2006) Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC). Clin Calcium 16:1017–1021PubMed Wada S, Kamiya S (2006) Bone and bone related biochemical examinations. Bone and collagen related metabolites. Osteocalcin (OC). Clin Calcium 16:1017–1021PubMed
19.
go back to reference Neve A, Corrado A, Cantatore FP (2013) Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228:1149–1153PubMedCrossRef Neve A, Corrado A, Cantatore FP (2013) Osteocalcin: skeletal and extra-skeletal effects. J Cell Physiol 228:1149–1153PubMedCrossRef
20.
go back to reference Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD (2000) Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 27:283–286PubMedCrossRef Chapurlat RD, Garnero P, Breart G, Meunier PJ, Delmas PD (2000) Serum type I collagen breakdown product (serum CTX) predicts hip fracture risk in elderly women: the EPIDOS study. Bone 27:283–286PubMedCrossRef
21.
go back to reference Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100–103PubMedCrossRef Rosen HN, Moses AC, Garber J, Iloputaife ID, Ross DS, Lee SL, Greenspan SL (2000) Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy. Calcif Tissue Int 66:100–103PubMedCrossRef
22.
go back to reference Fong L, Muhlhausler BS, Gibson RA, Xian CJ (2012) Perinatal maternal dietary supplementation of omega3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology 153:2455–2465PubMedCrossRef Fong L, Muhlhausler BS, Gibson RA, Xian CJ (2012) Perinatal maternal dietary supplementation of omega3-fatty acids transiently affects bone marrow microenvironment, osteoblast and osteoclast formation, and bone mass in male offspring. Endocrinology 153:2455–2465PubMedCrossRef
24.
go back to reference Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47:181–195PubMedCentralPubMedCrossRef Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47:181–195PubMedCentralPubMedCrossRef
25.
27.
go back to reference Dong XL, Zhang Y, Favus MJ, Che CT, Wong MS (2010) Ethanol extract of Fructus ligustri lucidi increases circulating 1,25-dihydroxyvitamin D3 by inducing renal 25-hydroxyvitamin D-1alpha hydroxylase activity. Menopause 17:1174–1181PubMedCrossRef Dong XL, Zhang Y, Favus MJ, Che CT, Wong MS (2010) Ethanol extract of Fructus ligustri lucidi increases circulating 1,25-dihydroxyvitamin D3 by inducing renal 25-hydroxyvitamin D-1alpha hydroxylase activity. Menopause 17:1174–1181PubMedCrossRef
28.
go back to reference Wu S, Ren S, Nguyen L, Adams JS, Hewison M (2007) Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148:3410–3418PubMedCrossRef Wu S, Ren S, Nguyen L, Adams JS, Hewison M (2007) Splice variants of the CYP27b1 gene and the regulation of 1,25-dihydroxyvitamin D3 production. Endocrinology 148:3410–3418PubMedCrossRef
29.
go back to reference Shi L, Ma Y, Cai Z (1998) Quantitative determination of salidroside and specnuezhenide in the fruits of Ligustrum lucidum Ait. by high performance liquid chromatography. Biomed Chromatogr 12:27–30PubMedCrossRef Shi L, Ma Y, Cai Z (1998) Quantitative determination of salidroside and specnuezhenide in the fruits of Ligustrum lucidum Ait. by high performance liquid chromatography. Biomed Chromatogr 12:27–30PubMedCrossRef
30.
go back to reference Lin HM, Yen FL, Ng LT, Lin CC (2007) Protective effects of Ligustrum lucidum fruit extract on acute butylated hydroxytoluene-induced oxidative stress in rats. J Ethnopharmacol 111:129–136PubMedCrossRef Lin HM, Yen FL, Ng LT, Lin CC (2007) Protective effects of Ligustrum lucidum fruit extract on acute butylated hydroxytoluene-induced oxidative stress in rats. J Ethnopharmacol 111:129–136PubMedCrossRef
31.
go back to reference Xia EQ, Yu YY, Xu XR, Deng GF, Guo YJ, Li HB (2012) Ultrasound-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait. Ultrason Sonochem 19:772–776PubMedCrossRef Xia EQ, Yu YY, Xu XR, Deng GF, Guo YJ, Li HB (2012) Ultrasound-assisted extraction of oleanolic acid and ursolic acid from Ligustrum lucidum Ait. Ultrason Sonochem 19:772–776PubMedCrossRef
32.
33.
go back to reference Lee SU, Park SJ, Kwak HB, Oh J, Min YK, Kim SH (2008) Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol Res 58:290–296PubMedCrossRef Lee SU, Park SJ, Kwak HB, Oh J, Min YK, Kim SH (2008) Anabolic activity of ursolic acid in bone: stimulating osteoblast differentiation in vitro and inducing new bone formation in vivo. Pharmacol Res 58:290–296PubMedCrossRef
34.
go back to reference Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S (2005) Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med 71:673–679PubMedCrossRef Li JX, Hareyama T, Tezuka Y, Zhang Y, Miyahara T, Kadota S (2005) Five new oleanolic acid glycosides from Achyranthes bidentata with inhibitory activity on osteoclast formation. Planta Med 71:673–679PubMedCrossRef
35.
go back to reference Sultana N (2011) Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem 26:616–642PubMedCrossRef Sultana N (2011) Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. J Enzyme Inhib Med Chem 26:616–642PubMedCrossRef
36.
go back to reference Sultana N, Ata A (2008) Oleanolic acid and related derivatives as medicinally important compounds. J Enzym Inhib Med Chem 23:739–756CrossRef Sultana N, Ata A (2008) Oleanolic acid and related derivatives as medicinally important compounds. J Enzym Inhib Med Chem 23:739–756CrossRef
37.
go back to reference Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X (2004) Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett 566:55–59PubMedCrossRef Murakami S, Takashima H, Sato-Watanabe M, Chonan S, Yamamoto K, Saitoh M, Saito S, Yoshimura H, Sugawara K, Yang J, Gao N, Zhang X (2004) Ursolic acid, an antagonist for transforming growth factor (TGF)-beta1. FEBS Lett 566:55–59PubMedCrossRef
38.
go back to reference Yoshimura H, Sugawara K, Saito M, Saito S, Murakami S, Miyata N, Kawashima A, Morimoto S, Gao N, Zhang X, Yang J (2003) In vitro TGF-beta1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus. Planta Med 69:673–675PubMedCrossRef Yoshimura H, Sugawara K, Saito M, Saito S, Murakami S, Miyata N, Kawashima A, Morimoto S, Gao N, Zhang X, Yang J (2003) In vitro TGF-beta1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus. Planta Med 69:673–675PubMedCrossRef
39.
41.
go back to reference Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435PubMedCrossRef Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435PubMedCrossRef
42.
go back to reference Quarles LD (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8:276–286PubMedCrossRef Quarles LD (2012) Skeletal secretion of FGF-23 regulates phosphate and vitamin D metabolism. Nat Rev Endocrinol 8:276–286PubMedCrossRef
43.
go back to reference Dangpei L (2010) Effects of FGF-23 overexpression on SOD and GSH2PX activity and MDA contents in mouse renal, hepatic and hippocampal tissues. J Southeast Univ (Med Sci Ed) 29:123–126 Dangpei L (2010) Effects of FGF-23 overexpression on SOD and GSH2PX activity and MDA contents in mouse renal, hepatic and hippocampal tissues. J Southeast Univ (Med Sci Ed) 29:123–126
Metadata
Title
Fructus ligustri lucidi Ethanol Extract Improves Bone Mineral Density and Properties Through Modulating Calcium Absorption-Related Gene Expression in Kidney and Duodenum of Growing Rats
Authors
Xin Feng
Ying Lyu
Zhenghao Wu
Yuehui Fang
Hao Xu
Pengling Zhao
Yajun Xu
Haotian Feng
Publication date
01-04-2014
Publisher
Springer US
Published in
Calcified Tissue International / Issue 4/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-013-9825-4

Other articles of this Issue 4/2014

Calcified Tissue International 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.